Healthcare
Phio Pharma – SUCCESS PAGE – June 29, 2026
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
EDV is developing a non-invasive drug delivery platform to transport therapeutics directly to the inner ear via ear drops
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
EDV is developing a non-invasive drug delivery platform to transport therapeutics directly to the inner ear via ear drops
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Object Pharma is creating a novel, non-systemic neurotoxin platform to help solve today’s mental health crisis
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.